Animal models of fibrosis (lung, liver, and kidney) have demonstrated S1P involvement in fibrotic development, and elevated serum S1P levels have been observed in SSc patients due to increased activation of platelet aggregation that occurs during SSc lesions. Here, MBTPS1 is linked to systemic sclerosis.